Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-12-08 pm EST
567.95 USD   +1.76%
12/08Thermo Fisher Scientific : Expands its Global Biologics and Steriles Manufacturing Capabilities in China
PU
12/07Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
AQ
12/07RBC Initiates Thermo Fisher Scientific at Outperform With $660 Price Target, Cites 'Advantageous Position'
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Inc. : Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 31, 2013

01/03/2013 | 08:35am EST

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the 2012 fourth quarter and full year before the market opens on Thursday, January 31, 2013, and will hold a conference call on the same day at 8:30 a.m. EST.

During the call, the company will discuss its fourth quarter and full year financial performance, as well as future expectations, including initial 2013 financial guidance. To listen, call (866) 804-6922 within the U.S. or (857) 350-1668 outside the U.S. and use conference ID 27442368. You may also listen to the call live on the "Investors" section of our website, www.thermofisher.com. The earnings press release and related information can be found in that section of our website under "Financial Results." A replay of the call will be available under "Webcasts and Presentations" through Friday, March 1, 2013.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.

Media Contact Information:
Ron O?Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com


ę Business Wire 2013
All news about THERMO FISHER SCIENTIFIC
12/08Thermo Fisher Scientific : Expands its Global Biologics and Steriles Manufacturing Capabil..
PU
12/07Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
AQ
12/07RBC Initiates Thermo Fisher Scientific at Outperform With $660 Price Target, Cites 'Adv..
MT
12/06Thermo Fisher Scientific Raises Greenhouse Gas Emissions Reduction Target on Path to Ne..
BU
12/06Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
CI
11/29Transcript : Thermo Fisher Scientific Inc. Presents at 5th Annual Evercore IS..
CI
11/29Barclays Cuts Price Target on Thermo Fisher to $570 From $575, Maintains Overweight Rat..
MT
11/21Thermo Fisher Scientific Issues 1.25 Billion Euros of 2026, 2034 Notes
MT
11/21Thermo Fisher Scientific Inc. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
11/21Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
BU
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 43 901 M - -
Net income 2022 6 919 M - -
Net Debt 2022 24 827 M - -
P/E ratio 2022 32,4x
Yield 2022 0,21%
Capitalization 224 B 224 B -
EV / Sales 2022 5,66x
EV / Sales 2023 5,54x
Nbr of Employees 130 000
Free-Float 88,9%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 567,95 $
Average target price 617,84 $
Spread / Average Target 8,78%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors